Incorporating Demand and Supply Constraints into Economic Evaluations in Low‐Income and Middle‐Income Countries
暂无分享,去创建一个
Nicola Foster | Anna Vassall | Gabriela B. Gomez | Lindsay Mangham‐Jefferies | Catherine Pitt | A. Vassall | L. Mangham-Jefferies | G. Gomez | N. Foster | C. Pitt
[1] Alan Shiell,et al. Complex interventions: how “out of control” can a randomised controlled trial be? , 2004, BMJ : British Medical Journal.
[2] Richard G. White,et al. Using the TIME model in Spectrum to estimate tuberculosis–HIV incidence and mortality , 2014, AIDS.
[3] Eric Obikeze,et al. Cost-effectiveness analysis of rapid diagnostic test, microscopy and syndromic approach in the diagnosis of malaria in Nigeria: implications for scaling-up deployment of ACT , 2009, Malaria Journal.
[4] S. Dorman,et al. Optimal Triage Test Characteristics to Improve the Cost-Effectiveness of the Xpert MTB/RIF Assay for TB Diagnosis: A Decision Analysis , 2013, PloS one.
[5] V. Wiseman,et al. Designing and implementing interventions to change clinicians’ practice in the management of uncomplicated malaria: lessons from Cameroon , 2014, Malaria Journal.
[6] A. Gheorghe,et al. The need for increased harmonisation of clinical trials and economic evaluations , 2014, Expert review of pharmacoeconomics & outcomes research.
[7] Richard G. White,et al. Modeling of Novel Diagnostic Strategies for Active Tuberculosis – A Systematic Review: Current Practices and Recommendations , 2014, PloS one.
[8] Richard Grieve,et al. Statistical Methods for Cost-Effectiveness Analyses That Use Data from Cluster Randomized Trials , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.
[9] Chantal Morel,et al. Cost-effectiveness of malaria diagnostic methods in sub-Saharan Africa in an era of combination therapy. , 2008, Bulletin of the World Health Organization.
[10] F. Masiye,et al. Cost-effectiveness analysis of the available strategies for diagnosing malaria in outpatient clinics in Zambia , 2009, Cost effectiveness and resource allocation : C/E.
[11] V. Wiseman,et al. Basic or enhanced clinician training to improve adherence to malaria treatment guidelines: a cluster-randomised trial in two areas of Cameroon. , 2014, The Lancet. Global health.
[12] Vikram Patel,et al. Theory of Change: a theory-driven approach to enhance the Medical Research Council's framework for complex interventions , 2014, Trials.
[13] C. Rogier,et al. Use of HRP-2-based rapid diagnostic test for Plasmodium falciparum malaria: assessing accuracy and cost-effectiveness in the villages of Dielmo and Ndiop, Senegal , 2010, Malaria Journal.
[14] Angel Rosas-Aguirre,et al. Relación costo-efectividad del uso de pruebas rápidas para el diagnóstico de la malaria en la Amazonia peruana , 2009 .
[15] S. Lawn,et al. Effect of empirical treatment on outcomes of clinical trials of diagnostic assays for tuberculosis. , 2015, The Lancet. Infectious diseases.
[16] J. Ndiaye,et al. Major Reduction in Anti-Malarial Drug Consumption in Senegal after Nation-Wide Introduction of Malaria Rapid Diagnostic Tests , 2011, PloS one.
[17] S. Basu,et al. Comparing Decisions for Malaria Testing and Presumptive Treatment , 2014, Medical decision making.
[18] V. Wiseman,et al. Economic evaluation of a cluster randomized trial of interventions to improve health workers' practice in diagnosing and treating uncomplicated malaria in Cameroon. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[19] C. Whitty,et al. The cost-effectiveness of parasitologic diagnosis for malaria-suspected patients in an era of combination therapy. , 2007, The American journal of tropical medicine and hygiene.
[20] R. Grieve,et al. Using multilevel models for assessing the variability of multinational resource use and cost data. , 2005, Health economics.
[21] W. MacLeod,et al. The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa , 2012, PloS one.
[22] Ted Cohen,et al. Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach. , 2014, The Lancet. Global health.
[23] Eduardo Gotuzzo,et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study , 2011, The Lancet.
[24] J. Eaton,et al. A Side Door Into Care Cascade for HIV-Infected Patients? , 2013, Journal of acquired immune deficiency syndromes.
[25] Grant Theron,et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial , 2014, The Lancet.
[26] Grant Russell,et al. Patient-centred access to health care: conceptualising access at the interface of health systems and populations , 2013, International Journal for Equity in Health.
[27] C. Fraser,et al. The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models , 2014, AIDS.
[28] R. Snow,et al. Modeling the financial and clinical implications of malaria rapid diagnostic tests in the case-management of older children and adults in Kenya. , 2008, The American journal of tropical medicine and hygiene.
[29] M Sculpher,et al. A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme. , 2004, Health technology assessment.
[30] K. Indaratna,et al. Determining cost-effectiveness and cost component of three malaria diagnostic models being used in remote non-microscope areas. , 2003, The Southeast Asian journal of tropical medicine and public health.
[31] H. Tinto,et al. Strict adherence to malaria rapid test results might lead to a neglect of other dangerous diseases: a cost benefit analysis from Burkina Faso , 2011, Malaria Journal.
[32] C. Whitty,et al. Cost-Effectiveness Analysis of Introducing RDTs for Malaria Diagnosis as Compared to Microscopy and Presumptive Diagnosis in Central and Peripheral Public Health Facilities in Ghana , 2013, The American journal of tropical medicine and hygiene.
[33] B. Marston,et al. Cost-Effectiveness of Tuberculosis Diagnostic Strategies to Reduce Early Mortality Among Persons With Advanced HIV Infection Initiating Antiretroviral Therapy , 2012, Journal of acquired immune deficiency syndromes.
[34] R. Walensky,et al. The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis , 2012, AIDS.
[35] A. Vassall,et al. Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review , 2015, PharmacoEconomics.
[36] K. Barnes,et al. Should countries implementing an artemisinin-based combination malaria treatment policy also introduce rapid diagnostic tests? , 2008, Malaria Journal.
[37] N. Ford,et al. Strength of recommendations in WHO guidelines using GRADE was associated with uptake in national policy. , 2015, Journal of clinical epidemiology.
[38] H-H Lin,et al. A modelling framework to support the selection and implementation of new tuberculosis diagnostic tools [State of the art series. Operational research. Number 8 in the series]. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[39] John Stover,et al. Towards an improved investment approach for an effective response to HIV/AIDS , 2011, The Lancet.
[40] J. Stover,et al. Methods used in the Lives Saved Tool (LiST) , 2011, BMC public health.
[41] F. Pang,et al. Generalisability in economic evaluation studies in healthcare: a review and case studies. , 2004, Health technology assessment.
[42] F. Checchi,et al. Operational response to malaria epidemics: are rapid diagnostic tests cost‐effective? , 2006, Tropical medicine & international health : TM & IH.
[43] R. Atun,et al. Integration of targeted health interventions into health systems: a conceptual framework for analysis. , 2010, Health policy and planning.
[44] B. Hamainza,et al. Relative costs and effectiveness of treating uncomplicated malaria in two rural districts in Zambia: implications for nationwide scale-up of home-based management , 2011, Malaria Journal.
[45] Anne Mills,et al. The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis , 2008, BMJ : British Medical Journal.
[46] B. Uzochukwu,et al. Effectiveness of Provider and Community Interventions to Improve Treatment of Uncomplicated Malaria in Nigeria: A Cluster Randomized Controlled Trial , 2015, PloS one.
[47] A. Dia,et al. Évaluation économique des tests de diagnostic rapide dans le traitement du paludisme , 2010 .
[48] P. Vickerman,et al. Parameterising User Uptake in Economic Evaluations: The role of discrete choice experiments , 2016, Health economics.
[49] Grant Theron,et al. Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting? , 2011, European Respiratory Journal.
[50] C. Whitty,et al. An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria , 2008, Malaria Journal.
[51] M. Sudhinaraset,et al. Cost-effectiveness analysis of malaria rapid diagnostic test incentive schemes for informal private healthcare providers in Myanmar , 2015, Malaria Journal.
[52] F. Althaus,et al. Over-diagnosis of malaria by microscopy in the Kilombero Valley, Southern Tanzania: an evaluation of the utility and cost-effectiveness of rapid diagnostic tests , 2013, Malaria Journal.
[53] Christopher Dye,et al. Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF. , 2015, The Lancet. Global health.
[54] Alan Shiell,et al. Complex interventions or complex systems? Implications for health economic evaluation , 2008, BMJ : British Medical Journal.
[55] C. Lengeler,et al. Cost Savings with Rapid Diagnostic Tests for Malaria in Low-Transmission Areas: Evidence from Dar es Salaam, Tanzania , 2010, The American journal of tropical medicine and hygiene.
[56] Andrea Manca,et al. Increasing the generalizability of economic evaluations: Recommendations for the design, analysis, and reporting of studies , 2005, International Journal of Technology Assessment in Health Care.
[57] M. R. F. de Oliveira,et al. Cost-effectiveness of diagnostic for malaria in Extra-Amazon Region, Brazil , 2012, Malaria Journal.
[58] M. Rowland,et al. Cost-effectiveness of malaria diagnosis using rapid diagnostic tests compared to microscopy or clinical symptoms alone in Afghanistan , 2015, Malaria Journal.
[59] Max O Bachmann,et al. Cost‐effectiveness of nurse‐led versus doctor‐led antiretroviral treatment in South Africa: pragmatic cluster randomised trial , 2013, Tropical medicine & international health : TM & IH.
[60] D. Dowdy,et al. Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings? , 2014, The Lancet. Infectious diseases.
[61] Andrew R Willan,et al. 'Lost in translation': accounting for between-country differences in the analysis of multinational cost-effectiveness data. , 2006, PharmacoEconomics.
[62] P. Magnussen,et al. Cost-effectiveness of malaria microscopy and rapid diagnostic tests versus presumptive diagnosis: implications for malaria control in Uganda , 2011, Malaria Journal.
[63] P. Palange,et al. From the authors , 2007, European Respiratory Journal.
[64] R. Atun,et al. A systematic review of the evidence on integration of targeted health interventions into health systems. , 2010, Health policy and planning.
[65] Mark Sculpher,et al. Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[66] J. Salomon,et al. Population Health Impact and Cost-Effectiveness of Tuberculosis Diagnosis with Xpert MTB/RIF: A Dynamic Simulation and Economic Evaluation , 2012, PLoS medicine.
[67] Anna Vassall,et al. Rapid Diagnosis of Tuberculosis with the Xpert MTB/RIF Assay in High Burden Countries: A Cost-Effectiveness Analysis , 2011, PLoS medicine.
[68] M. San Sebastiån,et al. Cost-effectiveness of three malaria treatment strategies in rural Tigray, Ethiopia where both Plasmodium falciparum and Plasmodium vivax co-dominate , 2011, Cost effectiveness and resource allocation : C/E.
[69] M. R. F. de Oliveira,et al. Cost effectiveness of OptiMal® rapid diagnostic test for malaria in remote areas of the Amazon Region, Brazil , 2010, Malaria Journal.
[70] A. Dia,et al. [Economic evaluation of rapid diagnostic tests in malaria treatment]. , 2010, Sante publique.